The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
Open accessAbstract
Objective To determine the prevalence of elevated total (TT) and free testosterone (FT), and DHEAS, alone and in combination, in polycystic ovary syndrome (PCOS) patients. Design Cross-sectional analysis Setting Tertiary care academic medical center Patients Seven hundred and twenty patients diagnosed with PCOS according to the NIH 1990 criteria. Interventions History and physical exam, and blood sampling. Main Outcome Measure(s) Hyperandrogenemia, defined as at least one androgen value above the 95th percentile of 98 healthy control women, i.e. TT >88 ng/dl, FT >0.75 ng/dl, and DHEAS >2750 ng/ml. Result(s) A total of 716 PCOS subjects were included. The overall, prevalence of hyperandrogenemia in PCOS was 75.3%. Supranormal levels of FT were present in 57.6%, of TT in 33.0%, and of DHEAS in 32.7% of PCOS patients. When assessing the prevalence of two abnormal values, the prevalence of simultaneously elevated androgens was lowest with TT and DHEAS (1.7%) and highest with TT and FT (20.4%). Altogether, simultaneous elevations in all three markers were found in 8.7% of PCOS subjects. Conclusion Approximately three-fourths of patients with PCOS diagnosed by the NIH 1990 criteria have evidence of hyperandrogenemia; the single most predictive assay was the measurement of FT with ∼60% of patients demonstrating supranormal levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationRosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Self-citationAndrogen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Self-citationEscobar-Morreale, H., Asuncion, M., Calvo, R., Sancho, J., & San Millan, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450619 · Cited by 81
Cited by
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Self-citationDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review
Pundir, C., Deswal, R., Narwal, V., & Dang, A. (2020) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_95_18 · Cited by 657
Current Guidelines for Diagnosing PCOS
Christ, J. P., & Cedars, M. I. (2023) · Diagnostics · doi:10.3390/diagnostics13061113 · Cited by 340
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
“It is reported that approximately 75% of PCOS patients have hyperandrogenism, and more than 80% of which demonstrate supranormal levels of free testosterone [81].”
Background
Metadata
- Authors
- Huang, A., Brennan, K., & Azziz, R.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 93
- Issue
- 6
- Pages
- 1938-1941
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2065989691
- Cited by
- 175
- References
- 5
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.